TP53 and prostate carcinoma: Remarkably, theaflavin also stimulated apoptosis by p53 expression, altering the Bax/Bcl-2 ratio, increased release of cytochrome c from mitochondria, and activates the caspases-9 and -3 expressions in prostate cancer cells [150].